Skip to main content

Table 1 Participants’ characteristics

From: C - reactive protein and interleukin - 6 levels among human immunodeficiency virus -infected patients with dysglycemia in Tanzania

Variables

Value (n = 240)

Age (mean ± SD)

47 ± 10

Education level (%)

 No formal

29 (12%)

 Primary

151(63%)

 Secondary and above

60(25%)

 Female

181(75%)

 Family history of diabetes type 2

19(9%)

 Current smoker (last 30 days)

5(3%)

 Consumed alcohol in the last 30 days

36(15%)

 Vigorous activity

90(37%)

 Walking/bicycle (> 10 min)

110(46%)

BMI (%)

 Normal+Underweight

130(58%)

 Overweight +Obese

58(42%)

Waist to height ratio (%)

  > 50%, (high)

215(89%)

 High blood pressure (≥140/90 mmHg)

53(22%)

Baseline VL (Copies/ml) (%)

 0–999

210(93%)

 1000+

15(7%)

 Baseline CD4 (mean ± SD)

288 ± 231

 CD 4 count after 6 months on ART(mean ± SD)

410 ± 223

 Current CD4 (mean ± SD)

520 ± 236

Type or ART

 Stavudine based regimen

71(29%)

 Zidovudine based regimen

86(35%)

 Tenofovir based regimen

83(34%)

 Efavirenz containing regimen

205(86%)

 Median ART duration in years (IQR)

8(5–10)